SimpsonSJrBlizzardLOtahalPet al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry2011; 82: 1132–1141.
2.
ForrestKYStuhldreherWL.Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res2011; 31: 48–54.
3.
WackerMHolickMF.Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation. Nutrients2013; 5: 111–148.
4.
MungerKLZhangSMO’ReillyEet al. Vitamin D intake and incidence of multiple sclerosis. Neurology2004; 62: 60–65.
5.
MungerKLLevinLIHollisBWet al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006; 296: 2832–2838.
6.
SalzerJHallmansGNystromMet al. Vitamin D as a protective factor in multiple sclerosis. Neurology2012; 79: 2140–2145.
7.
MungerKLHongellKAivoJet al. 25-hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort. Neurology2017; 89: 1578–1583.
8.
NielsenNMMungerKLKoch-HenriksenNet al. Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Neurology2017; 88: 44–51.
9.
CantornaMTHayesCEDe LucaHF.1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A1996; 93: 7861–7864.
10.
CantornaMTZhuYFroicuMet al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr2004; 80: 1717S–1720S.
11.
MokryLERossSAhmadOSet al. Vitamin D and risk of multiple sclerosis: A Mendelian randomization study. PLoS Med2015; 12: e1001866.
12.
RheadBBäärnhielmMGianfrancescoMet al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet2016; 2: e97.
13.
GianfrancescoMAStridhPRheadBet al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology2017; 88: 1623–1629.
